Moderna (MRNA) Share-based Compensation Growth (1y) (2019 - 2026)
Moderna (MRNA) Share-based Compensation Growth (1y) (2019 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Stock Comp. Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-69.95% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
0.18% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Moderna |
25.27 Bn |
20.06 Bn |
-566.00 Mn |
-9.57% |
| Date | Value |
|---|
| Mar 31, 2026 |
-9.57% |
| Dec 31, 2025 |
8.65% |
| Sep 30, 2025 |
11.61% |
| Jun 30, 2025 |
16.07% |
| Mar 31, 2025 |
13.86% |
| Dec 31, 2024 |
31.65% |
| Sep 30, 2024 |
45.45% |
| Jun 30, 2024 |
51.35% |
| Mar 31, 2024 |
34.67% |
| Dec 31, 2023 |
27.42% |
| Sep 30, 2023 |
10.00% |
| Jun 30, 2023 |
48.00% |
| Mar 31, 2023 |
70.45% |
| Dec 31, 2022 |
67.57% |
| Sep 30, 2022 |
75.00% |
| Jun 30, 2022 |
42.86% |
| Mar 31, 2022 |
46.67% |
| Dec 31, 2021 |
42.31% |
| Sep 30, 2021 |
81.82% |
| Jun 30, 2021 |
40.00% |
